Immunomodulatory and anti-inflammatory activity induced by oral administration of a probiotic strain of Lactobacillus casei

European Journal of Inflammation

Volumn 4, Issue 1, 2006, Pages 31-41

  Bonet, M E Bibas ^a   Chaves, A S ^a,b   Meson O ^a   Perdigón, Gabriela ^a,b  

^a UNIVERSIDAD NACIONAL DE TUCUMÁN   (Argentina)

^b CENTRO DE REFERENCIA PARA LACTOBACILOS CERELA CONICET   (Argentina)

Author keywords

BALT; GALT; L. casei; Mucosal immunity; Probiotic bacterium

Indexed keywords

ALPHA INTERFERON; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN A; INTERLEUKIN 10; INTERLEUKIN 4; PROBIOTIC AGENT; REGULATOR PROTEIN;

ANIMAL EXPERIMENT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BACTERIAL STRAIN; BRONCHUS MUCOSA; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFICACY; HISTOLOGY; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOFLUORESCENCE TEST; IMMUNOGLOBULIN PRODUCTION; IMMUNOMODULATION; IMMUNOSTIMULATION; LACTOBACILLUS CASEI; MILK; MOUSE; MOUSE STRAIN; MUCOSAL IMMUNITY; NONHUMAN; OPTIMAL DRUG DOSE; PERITONEUM MACROPHAGE; PHAGOCYTOSIS; PROTEIN ANALYSIS; SMALL INTESTINE MUCOSA; TREATMENT DURATION;

EID: 33646781926     PISSN: 1721727X     EISSN: None     Source Type: Journal    
DOI: 10.1177/1721727X0600400104     Document Type: Article

References (26)

1. Marteau P. and J.C. Rambaud. 1993. Potential of using lactic acid bacteria for therapy and immunomodulation in man. FEMS. Microbiol. Rev. 12:207.
2. Schiffrin E.J., D. Brassart, A.L. Servin, F. Rochat and A. Donnet-Hughes. 1997. Immune modulation of blood leukocytes in humans by lactic acid bacteria: criteria for strain selection. Am. J. Clin. Nutr. 66: 515.
3. Schiffrin E.J., F. Rochat, H. Link.Amster, J. Aeschlimann and A. Donnet-Hughes. 1995. Immunomodulation of human blood cells following the ingestion of lactic acid bacteria. J. Dairy Sci. 78: 491.
4. Vintiñi E., S. Alvarez, M. Medina, M. Médici, M.V. de Budeguer and G. Perdigón. 2000. Gut mucosal immunostimulation by lactic acid bacteria. Biocell 24:223.
5. Perdigón G., M.E. Bibas Bonet de Jorrat, S. Fontenla de Petrino and M. Rachid. 1993. Antitumor activity of orally administered Lactobacillus casei: significance of its dose in the inhibition of a fibrosarcoma in mice. Food & Agric. Immunol. 5:39.
6. Perdigón G., M. Medici, M.E. Bibas Bonet de Jorrat, M. Valverde and A. Pesce de Ruiz Holgado. 1993. Immunomodulating effects of lactic acid bactéria on mucosal and tumoral immunity. Int. J. Immunoth. 9:29.
7. Perdigón G., S. Alvarez and A.P. de Ruiz Holgado. 1991. Oral immunoadjuvant activity of L. casei influence of the dose administered on the secretory immune response and protective capacity in intestinal infections. J. Dairy Res. 58:485.
8. Perdigón G., S.Alvarez, N. Gobbato, M. de Budeguer and A.P. de Ruiz Holgado. 1995. Comparative effect of the adjuvant capacity of L. casei and LPS on the intestinal secretory antibody response and resistance to salmonella infection in mice. J. Agr. Immunol. 7:283.
9. Alvarez S., N. Gobbato, E. Bru, A.P. de Ruiz Holgado and G. Perdigón. 1998. Specific immunity induction at mucosal level by viable Lactobacillus casei. Perspective for oral vaccine development. Food Agricul. Immunol. 10:79.
10. Perdigón G., C. Maldonado Galdeano, J.C. Valdez and M. Medici. 2002. Interaction of lactic acid bacteria with the gut immune system. Eur. J. Clin. Nutr: 56:21.
11. Sanders M.E. 1993. Effects of consumption of lactic cultures on human health. Adv. Food Nutr. Res. 17:67.
12. Mowat A.M. 2003. Anatomical of tolerance and Immunity to intestinal antigens. Nat. Rev. Immunology 3:331.
13. Perdigón, G., M. Medina, E. Vintiñi and J.C. Valdez. 2000. Intestinal pathway of internalization of lactic acid bacteria and gut mucosal immunostimulation. Int. J. Immunopathol. Pharmacol. 13:141.
14. Maldonado Galdeano C.M. and G. Perdigón. 2004. Role of viability of probiotic strains in their persistence in the gut and in mucosal immune stimulation. J. Appl. Microbiol. 4:673.
15. Sainte-Marie G. 1966. A paraffin embedding technique for studies employing immunofluorescence. Proc. Sac. Exp. Biol. Med. 122:696.
16. Sartor R.B. 1990. Role of intestinal microflora in initiation and perpetuation of inflammatory bowel disease. Can. J. Gastroenterol. 4:271.
17. 3H/He J mice. Infect. Immun. 56:2766.
18. Weinstein P.D. and J.J. Cebra. 1991. The preference for switching to IgA expression by Peyer's patch germinal center B cells is likely due to the intrinsic influence of their environment. J. Immunol. 147:4126.
19. Becker C. and M.F. Neurath. 2004. Lamina propria dendritic cells mediate localized mucosal immuno response. Mucosal Immunology Update 12:4.
20. Nagler-Anderson C. 2001. Strategic defenses in the intestinal mucosa. Nat. Rev. Immunol. 1:59.
21. Lamm M.E., J.G. Nedrud, C.S. Kaetzel and M.B. Mazanec. 1996. New insights into epithelial cell function. In Mucosal Immunity: Neutralization of intracellular pathogens and excretion of antigens by IgA. M.F. Kagnoff and H. Kiyono, ed. Academic Press Inc San Diego California USA, p. 141.
22. Bilsborough J. and J.L. Viney. 2004. Directing the balance between intestinal homeostasis and active immunity: are gut plasmacytoid dendritic cell by to regulating intestinal immunity? Mucosal Immunology Update 12:8.
23. Marquez M.G., G.A. Sosa and M.E. Roux. 2000. Developmental study of immunocompetent cell in bronchus-associated lymphoid tissue (BALT) from Wistar rat. Dev. Comp. Immunol. 24:386.
24. Perdigón G., S. Alvarez, M. Medina, E. Vintiñi and E. Roux. 1999. Influence of the oral administration of lactic acid bacteria on IgA producing cells associated to bronchus. Int. J. Immunopathol. Pharmacol. 12:97.
25. Brandtzaeg P. and R. Pabst. 2004. Let's go mucosal: communication on slippery ground. Trends Immunol. 25:570.
26. de Moreno de LeBlanc A., C. Maldonado Galdeano, S. Chaves and G. Perdigón. 2005. Oral administration of L. casei CRL 431 increases immunity in bronchus and mammary glands. Eur. J. Inflamm. 3:25.